About Robotic General Surgery
Robotic surgery or robot-assisted surgery is a minimally invasive surgery that integrates advanced computer technology, which provides 10x magnified, high-definition, and 3D-image of the body's intricate anatomy. Robotic surgery systems are used in a wide range of surgical procedures including general surgery, colorectal, cardiac, head and neck, gynecologic, thoracic, and urologic surgical procedures. Some of the general surgery procedures where robotic surgical systems are used are bariatric surgery (gastric bypass and sleeve gastrectomy), Heller myotomy, stomach cancer surgery, hernia repair, cholecystectomy, Nissen fundoplication, and pancreatectomy. Robotic surgery offers several advantages such as a 3D view of the operating field, low risk of infection, reduced blood loss and transfusions, fast recovery time, early discharge from hospital, minimal scarring, less post-operative pain and trauma to the body, and more precision in surgery due to the elimination of surgeon's tremor.
Technavio’s analysts forecast the global robotic general surgery market to grow at a CAGR of 10.53% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global robotic general surgery market for 2017-2021. To calculate the market size, the report considers the revenues generated from the sales of robotic general surgery systems, robotic surgical instruments and accessories, and robotic surgical services.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Robotic General Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Accuray
• Intuitive Surgical
• Medrobotics Corporation
• TransEnterix Surgical
Other prominent vendors
• meerecompany
• Titan Medical
• Verb Surgical
• Virtual Incision Corporation
Market driver
• Increasing number of general surgery procedures
• For a full, detailed list, view our report
Market challenge
• High cost of robotic general surgery devices
• For a full, detailed list, view our report
Market trend
• Technological advances
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Overview
PART 05: MARKET LANDSCAPE
• Overview
• Market size and forecast
• Five forces analysis
PART 06: SEGMENTATION BY COMPONENT
• Overview
• Global robotic surgical instruments and accessories market
• Global robotic general surgery systems market
• Global robotic surgical services market
PART 07: SEGMENTATION BY GEOGRAPHY
• Overview
• Robotic general surgery market in Americas
• Robotic general surgery market in EMEA
• Robotic general surgery market in APAC
PART 08: MARKET SEGMENTATION BY END-USERS
• Market overview
• Hospitals
• ASCs
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Increasing focus toward development of low-cost robotic surgical systems
• Technological advances
• Increasing number of strategic collaborations
PART 12: VENDOR LANDSCAPE
• Competitive landscape
PART 13: KEY VENDOR ANALYSIS
• Accuray
• Intuitive Surgical
• Medrobotics Corporation
• TransEnterix Surgical
• Other prominent vendors
PART 14: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Global robotic general surgery market segmentation 2016
Exhibit 02: Total number of worldwide installations and unit shipments of Intuitive Surgical' s robotic surgical systems 2012-2016
Exhibit 03: Global robotic general surgery market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global robotic general surgery market by component 2016 (%)
Exhibit 06: Global robotic surgical instruments and accessories market 2016-2021 ($ millions)
Exhibit 07: Global robotic general surgery systems market 2016-2021 ($ millions)
Exhibit 08: Major robotic general surgery systems available in the market
Exhibit 09: Global robotic surgical services market 2016-2021 ($ millions)
Exhibit 10: Global robotic general surgery market by geography 2016 (%)
Exhibit 11: Robotic general surgery market in Americas 2016-2021 ($ millions)
Exhibit 12: Total number of installations and unit shipments of Intuitive Surgical' s robotic surgical systems in US 2012-2016
Exhibit 13: Robotic general surgery market in EMEA 2016-2021 ($ millions)
Exhibit 14: Total installations of Intuitive Surgical's robotic surgical systems in Europe 2012-2016
Exhibit 15: Robotic general surgery market in APAC 2016-2021 ($ millions)
Exhibit 16: Global robotic general surgery market by end-users 2016 (%)
Exhibit 17: Global robotic general surgery market: Competitive structure analysis 2016
Exhibit 18: Accuray: Key highlights
Exhibit 19: Accuray: Strength assessment
Exhibit 20: Accuray: Strategy assessment
Exhibit 21: Accuray: Opportunity assessment
Exhibit 22: Intuitive Surgical: Key highlights
Exhibit 23: Intuitive Surgical: Strength assessment
Exhibit 24: Intuitive Surgical: Strategy assessment
Exhibit 25: Intuitive Surgical: Opportunity assessment
Exhibit 26: Medrobotics Corporation: Key highlights
Exhibit 27: Medrobotics Corporation: Strength assessment
Exhibit 28: Medrobotics Corporation: Strategy assessment
Exhibit 29: Medrobotics Corporation: Opportunity assessment
Exhibit 30: TransEnterix Surgical: Key highlights
Exhibit 31: TransEnterix Surgical: Strength assessment
Exhibit 32: TransEnterix Surgical: Strategy assessment
Exhibit 33: TransEnterix Surgical: Opportunity assessment
